.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Covington
Dow
US Army
McKesson
Daiichi Sankyo
Moodys
Fuji
QuintilesIMS
Teva
Chinese Patent Office

Generated: July 27, 2017

DrugPatentWatch Database Preview

Diflunisal - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for diflunisal and what is the scope of diflunisal freedom to operate?

Diflunisal
is the generic ingredient in two branded drugs marketed by Watson Labs, Idt Australia Ltd, Heritage Pharma, Merck, Zydus Pharms Usa Inc, Roxane, Teva, and Purepac Pharm, and is included in ten NDAs. Additional information is available in the individual branded drug profile pages.

There are seven drug master file entries for diflunisal. Five suppliers are listed for this compound.

Summary for Generic Name: diflunisal

Tradenames:2
Patents:0
Applicants:8
NDAs:10
Drug Master File Entries: see list7
Suppliers / Packagers: see list5
Bulk Api Vendors: see list63
Clinical Trials: see list6
Patent Applications: see list5,437
Therapeutic Class:Anti-inflammatory Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:diflunisal at DailyMed

Pharmacology for Ingredient: diflunisal

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Teva
DIFLUNISAL
diflunisal
TABLET;ORAL073673-001Jul 31, 1992ABRXNoYes► Subscribe► Subscribe► Subscribe
Teva
DIFLUNISAL
diflunisal
TABLET;ORAL073679-001Jul 31, 1992DISCNNoNo► Subscribe► Subscribe► Subscribe
Purepac Pharm
DIFLUNISAL
diflunisal
TABLET;ORAL074285-001May 7, 1996DISCNNoNo► Subscribe► Subscribe► Subscribe
Roxane
DIFLUNISAL
diflunisal
TABLET;ORAL073562-001Nov 27, 1992DISCNNoNo► Subscribe► Subscribe► Subscribe
Heritage Pharma
DIFLUNISAL
diflunisal
TABLET;ORAL202845-001Mar 8, 2012ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: diflunisal

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Merck
DOLOBID
diflunisal
TABLET;ORAL018445-001Apr 19, 1982► Subscribe► Subscribe
Merck
DOLOBID
diflunisal
TABLET;ORAL018445-002Apr 19, 1982► Subscribe► Subscribe
Merck
DOLOBID
diflunisal
TABLET;ORAL018445-002Apr 19, 1982► Subscribe► Subscribe
Merck
DOLOBID
diflunisal
TABLET;ORAL018445-001Apr 19, 1982► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Deloitte
Fish and Richardson
Dow
Cantor Fitzgerald
Farmers Insurance
AstraZeneca
Johnson and Johnson
UBS
Merck
Covington

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot